Zimmer Biomet Holdings, Inc. (ZBH)
105.59
-1.26
(-1.18%)
USD |
NYSE |
Nov 06, 16:00
105.57
-0.02
(-0.02%)
After-Hours: 20:00
Zimmer Biomet Holdings Research and Development Expense (Quarterly) : 105.90M for Sept. 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 105.90M |
| June 30, 2026 | 104.80M |
| March 31, 2026 | 103.40M |
| December 31, 2025 | 118.80M |
| September 30, 2025 | 115.90M |
| June 30, 2025 | 113.30M |
| March 31, 2025 | 110.60M |
| December 31, 2024 | 108.40M |
| September 30, 2024 | 111.60M |
| June 30, 2024 | 109.40M |
| March 31, 2024 | 107.90M |
| December 31, 2023 | 113.30M |
| September 30, 2023 | 116.90M |
| June 30, 2023 | 118.10M |
| March 31, 2023 | 110.40M |
| December 31, 2022 | 108.00M |
| September 30, 2022 | 101.70M |
| June 30, 2022 | 99.40M |
| March 31, 2022 | 96.90M |
| December 31, 2021 | 96.00M |
| September 30, 2021 | 93.80M |
| June 30, 2021 | 165.00M |
| March 31, 2021 | 81.00M |
| December 31, 2020 | 100.00M |
| September 30, 2020 | 85.90M |
| Date | Value |
|---|---|
| June 30, 2020 | 87.70M |
| March 31, 2020 | 98.40M |
| December 31, 2019 | 121.10M |
| September 30, 2019 | 114.40M |
| June 30, 2019 | 112.10M |
| March 31, 2019 | 101.70M |
| December 31, 2018 | 101.20M |
| September 30, 2018 | 95.70M |
| June 30, 2018 | 99.10M |
| March 31, 2018 | 95.70M |
| December 31, 2017 | 95.00M |
| September 30, 2017 | 91.20M |
| June 30, 2017 | 92.60M |
| March 31, 2017 | 91.10M |
| December 31, 2016 | 95.70M |
| September 30, 2016 | 95.60M |
| June 30, 2016 | 88.60M |
| March 31, 2016 | 85.70M |
| December 31, 2015 | 85.90M |
| September 30, 2015 | 83.30M |
| June 30, 2015 | 51.40M |
| March 31, 2015 | 48.40M |
| December 31, 2014 | 46.60M |
| September 30, 2014 | 46.10M |
| June 30, 2014 | 48.10M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 408.20M |
| Stryker Corp. | 417.00M |
| Globus Medical, Inc. | 34.53M |
| Inspire Medical Systems, Inc. | 22.18M |
| Edwards Lifesciences Corp. | 281.40M |